Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Alexander Leads Bipartisan Support for Accelerated FDA Reviews


 

On Aug. 2, the U.S. Senate passed bipartisan legislation led by health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed approval of safe drugs and medical devices.

Alexander said: "The Senate has sent to the president's desk legislation that will speed cures and treatments into patients' medicine cabinets. The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- ensuring patients see the benefits of those research advancements."

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last year and a half, the HELP Committee that Alexander chairs has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

The bill includes provisions from:

  • Sens. Isakson and Bennet to improve the medical device inspection process.
  • Sens. Hassan and Young to improve communication about abuse-deterrent opioid products.
  • Sens. Enzi and Franken to encourage medical device development for children, and make sure FDA has appropriate expertise to review devices for children.
  • Sens Roberts, Donnelly, and Burr to allow more appropriate classification of accessories used with medical devices.
  • Sens Collins, Franken, McCaskill, and Cotton to improve generic drug development and help lower prescription drug costs.
  • Sens. Hatch, Bennet, Burr, and Casey to improve access to clinical trials for all patients.
  • Sens. Bennet, Rubio, Van Hollen, and Gardner to increase the development of new drugs to treat pediatric cancers and other diseases.
 
Share:

Related Articles:


Recent Articles

The Promise of Blockchain

Change Healthcare's Aaron Symanski says there are a lot of questions around blockchain ... and that's a good thing because it means there are many uses for the transformational technology in healthcare.

Read More

Change Healthcare Launches First Blockchain Solution

On Sept. 25, Change Healthcare announced the launch of the first blockchain solution for enterprise-scale use in healthcare, enabling payers and providers to boost revenue cycle efficiency, improve real-time analytics, cut costs, and create innovative new services.

Read More

NMGMA: 10 Minute Takeaway

The one constant is change - MGMA Associate Director of Government Affairs recently briefed practice managers on the latest from Washington, D.C.

Read More

M&A Trends & Technology

Even in an uncertain landscape, healthcare deals are getting done ... but buyers and sellers are becoming more discriminate.

Read More

THA Launches Data Sharing Initiative for TennCare Patients

New data sharing software is expected to improve communication, decrease emergency visits for TennCare patients

Read More

TOA Update

The state's largest orthopaedic surgery group continues to expand its offerings.

Read More

Innovation in Orthopaedics

Lorio's living hinge cages expected to change the future of spinal surgery.

Read More

The M&A Perspective

There's more to joining forces than signing on the dotted line. Jeff Seraphine, LifePoint Health's M&A chief, shares his insights on making what looks good on paper work in practice, as well.

Read More

The Little Clinic: Retail Health in the Continuum of Care

A rise in healthcare consumerism, patient demand for convenience and pricing clarity, and a looming provider shortage in some markets have helped fuel the growth of The Little Clinic and other retail health providers.

Read More

Novel Knee Surgery Uses Patient's Regrown Cartilage Cells

Vanderbilt has become the first in Tennessee to perform next gen knee surgery with an implant containing the patient's own regrown cartilage cells.

Read More

Email Print
 
 

 

 


Tags:
FDA, HELP Committee, Lamar Alexander, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: